Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
This study, published in JAMA Internal Medicine, outlines the controversy of nonbeneficial medication and treatment in long-term care environments.
Jennifer Tija, MD, of the University of Massachusetts Medical School in Worcester, and colleagues aimed to estimate the prevalence of medications with questionable benefit used by nursing home residents with advanced dementia, identify resident- and facility-level characteristics associated with such use, and estimate associated medication expenditures.
Of 5406 nursing home residents with advanced dementia, 2911 (53.9%) received at least 1 medication with questionable benefit.
READ FULL ARTICLE
From Jamanetwork
